Drug Safety Debate Will Have Long-Term Effect On New Approvals, Troy Says
Executive Summary
The current debate over drug safety will have a visible impact on new drug approvals in up to three years, former FDA Chief Counsel Dan Troy said
You may also be interested in...
FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch
Despite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public
FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch
Despite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public
FDA "Drug Watch" Listing Removal Criteria Need Greater Clarity - PhRMA
FDA's criteria for removing a product from the proposed "Drug Watch" website are subjective and will make it difficult, if not impossible, for a drug to be taken off the list, the Pharmaceutical Research & Manufacturers of America said